[18F]FMeNER-D2: Reliable fully-automated synthesis for visualization of the norepinephrine transporter

Nuclear Medicine and Biology

Volumn 40, Issue 8, 2013, Pages 1049-1054

  Rami Mark, Christina ^a,b   Zhang, Ming Rong ^c   Mitterhauser, Markus ^a,d   Lanzenberger, Rupert ^a   Hacker, Marcus ^a   Wadsak, Wolfgang ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Automation; Fluorine 18; FMeNER; FMeNER D2; Norepinephrine transporter; PET; Radiosynthesis

Indexed keywords

1 BROMO 2 FLUOROMETHANE D2 F 18; 2 [ALPHA (2 (DIDEUTEROFLUOROMETHOXY)PHENOXY)(PHENYL)METHYL]MORPHOLINE F 18; FLUORINE 18; NORADRENALIN TRANSPORTER; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; 2 (ALPHA (2 FLUOROMETHOXYPHENOXY)BENZYL)MORPHOLINE; 2-(ALPHA-(2-FLUOROMETHOXYPHENOXY)BENZYL)MORPHOLINE; DIAGNOSTIC AGENT; MORPHOLINE DERIVATIVE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MALE; POSITRON EMISSION TOMOGRAPHY; RADIATION SAFETY; RADIOACTIVITY; RADIOASSAY; RADIOISOTOPE DISTRIBUTION; REACTION TIME; STANDARDIZATION; AUTOMATION; CHEMISTRY; FLUORINE-18; FMENER; FMENER-D2; INJECTION; METABOLISM; METHODOLOGY; PET; RADIOCHEMISTRY; RADIOSYNTHESIS; SYNTHESIS;

AUTOMATION; FLUORINE-18; FMENER; FMENER-D2; NOREPINEPHRINE TRANSPORTER; PET; RADIOSYNTHESIS;

AUTOMATION; HUMANS; INJECTIONS; MORPHOLINES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

EID: 84886264530     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2013.08.007     Document Type: Article

References (28)

1. Zhou J. Norepinephrine transporter inhibitors and their therapeutic potential. Drugs Future 2004, 29:1235-1244.
2. Curatolo P., D'Agati E., Moavero R. The neurobiological basis of ADHD. Ital J Pediatr 2010, 36:79.
3. Mash D.C., Ouyang Q., Qin Y., Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. J Neurosci Methods 2005, 143:79-85.
4. Smith H.R., Beveridge T.J.R., Porrino L.J. Distribution of norepinephrine transporters in the non-human primate brain. Neuroscience 2006, 138:703-714.
5. Tejani-Butt S.M. [3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J Pharmacol Exp Ther 1992, 260:427-436.
6. Ordway G.A., Stockmeier C.A., Cason G.W., Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci 1997, 17:1710-1719.
7. Donnan G.A., Kaczmarczyk S.J., Paxinos G., Chilco P.J., Kalnins R.M., Woodhouse D.G., et al. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography. J Comp Neurol 1991, 304:419-434.
8. 3H]desipramine-binding sites in human postmortem brain tissue. Neuropsychobiology 1990, 23:68-73.
9. Logan J., Wang G.-j., Telang F., Fowler J.S., Alexoff D., Zabroski J., et al. Imaging the norepinephrine transporter in humans with (S, S)-[11C]O-methyl reboxetine and PET: problems and progress. Nucl Med Biol 2007, 34:667-679.
10. Kung M.-P., Choi S.-R., Hou C., Zhuang Z.-P., Foulon C., Kung H.F. Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain. Nucl Med Biol 2004, 31:533-541.
11. Halldin C., Farde L., Högberg T., Mohell N., Hall H., Suhara T., et al. Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nucl Med 1995, 36:1275-1281.
12. Fowler J.S., Volkow N.D., Wang G.-J., Gatley S.J., Logan J. [11]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol 2001, 28:561-572.
13. Pristupa Z.B., Wilson J.M., Hoffman B.J., Kish S.J., Niznik H.B. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Mol Pharmacol 1994, 45:125-135.
14. Ding Y.-S., Lin K.-S., Logan J., Benveniste H., Carter P. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S, S) and (R, R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine. J Neurochem 2005, 94:337-351.
15. Ding Y.-S., Lin K.-S., Garza V., Carter P., Alexoff D., Logan J., et al. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse 2003, 50:345-352.
16. Ding Y.-S., Singhal T., Planeta-Wilson B., Gallezot J.-D., Nabulsi N., Labaree D., et al. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S, S)-[11C]O-methylreboxetine and HRRT. Synapse 2010, 64:30-38.
17. Lin K.-S., Ding Y.-S. Synthesis and C-11 labeling of three potent norepinephrine transporter selective ligands ((R)-nisoxetine, lortalamine, and oxaprotiline) for comparative PET studies in baboons. Bioorg Med Chem 2005, 13:4658-4666.
18. Lin K.-S., Ding Y.-S., Kim S.-W., Kil K.-E. Synthesis, enantiomeric resolution, F-18 labeling and biodistribution of reboxetine analogs: promising radioligands for imaging the norepinephrine transporter with positron emission tomography. Nucl Med Biol 2005, 32:415-422.
19. Wilson A.A., Patrick Johnson D., Mozley D., Hussey D., Ginovart N., Nobrega J., et al. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. Nucl Med Biol 2003, 30:85-92.
20. Nguyen V.L., Pichika R., Bhakta P.H., Kant R., Mukherjee J. (R)-N-Methyl-3-(3'-[18F]fluoropropyl)phenoxy-3- phenylpropanamine (18F-MFP3) as a potential PET imaging agent for norepinephrine transporter. J Labelled Comps Radiopharm 2010, 53:172-177.
21. Schou M., Halldin C., Sóvágó J., Pike V.W., Hall H., Gulyás B., et al. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 2004, 53:57-67.
22. Schou M., Halldin C., Pike V.W., Mozley P.D., Dobson D., Innis R.B., et al. Post-mortem human brain autoradiography of the norepinephrine transporter using (S, S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol 2005, 15:517-520.
23. Gulyás B., Brockschnieder D., Nag S., Pavlova E., Kása P., Beliczai Z., et al. The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer's disease: a post-mortem autoradiographic study. Neurochem Int 2010, 56:789-798.
24. Lemaire C., Plenevaux A., Aerts J., Del Fiore G., Brihaye C., Le Bars D., et al. Solid phase extraction-an alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals. J Label Compd Radiopharm 1999, 42:63-75.
25. Gomzina N.A., Vasil'ev D.A., Krasikova R.N. Use of 2-[18F]fluoroethyl bromide in synthesis of O-(2'-[18F]fluoroethyl)-L-tyrosine, a radiotracer for PET diagnostics of brain tumors. Radiochemistry (N. Y., NY, U. S.) 2007, 49:299-304.
26. Murali D, Vandehey N, Christian B, Nickles J, Houser E, Converse A, et al. An efficient synthesis of F18-FECNT, a PET tracer for dopamine transporter. J NUCL MED MEETING ABSTRACTS 2008;49:288P-a-
27. Philippe C., Ungersboeck J., Schirmer E., Zdravkovic M., Nics L., Zeilinger M., et al. [18F]FE@SNAP-a new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): microfluidic and vessel-based approaches. Bioorg Med Chem 2012, 20:5936-5940.
28. Wadsak W., Mien L.K., Ettlinger D.E., Eidherr H., Haeusler D., Sindelar K.M., et al. 18F-fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers. Nucl Med Biol 2007, 34:1019-1028.